4//SEC Filing
Martin Samuel Bates 4
Accession 0001709024-26-000002
CIK 0000744218other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:23 PM ET
Size
7.1 KB
Accession
0001709024-26-000002
Insider Transaction Report
Form 4
Martin Samuel Bates
SVP AND CFO
Transactions
- Exercise/Conversion
Common Stock
2026-01-02$10.38/sh+4,817$50,000→ 32,942 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2026-01-02−4,817→ 58,815 totalExercise: $10.38Exp: 2030-06-18→ Common Stock (4,817 underlying)
Footnotes (1)
- [F1]As of June 18, 2024, the option is fully vested.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001709024
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:23 PM ET
- Size
- 7.1 KB